Balanced news tone
News Sentiment
AMGN sentiment intelligence
Amgen Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
55
Balanced news tone
51 relevant articles
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
-2.9% over one week, +2.3% over four weeks, trend active, and near fair-value range.
Wealthfront Advisers LLC Boosts Position in Amgen Inc. $AMGN
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
81/100 classification
One-week reaction
-2.9%
Price reacting lower
Trend fit
Trend active
2.3% over four weeks
Fair value
24.9%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
19
Neutral
27
Negative
5
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Ad Hoc News
Direct company coverage
Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term story
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 18:37
- Source
- Ad Hoc News
Ad Hoc News
Direct company coverage
Amgen stock holds steady as biotech pipeline and U.S. market listing shape long-term investor expect
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jul 2026 09:32
- Source
- Ad Hoc News
Ad Hoc News
Direct company coverage
Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term growth narr
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jul 2026 18:02
- Source
- Ad Hoc News
Ad Hoc News
Direct company coverage
Amgen strengthens its biotech footprint as investors track long-term growth drivers
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 12:24
- Source
- Ad Hoc News
Market source
Direct company coverage
Amgen (AMGN) Stock Dips While Market Gains: Key Facts
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Amgen (AMGN) Stock Is Up, What You Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Amgen or Biogen: Which Biotech Stock Appears Better Poised?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Amgen (AMGN) Stock Weighs Strong Run Against Mixed Valuation Signals
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Amgen (AMGN) Stock After Horizon Deal And Strong Multi‑Year Gains Is Price Still Reasonable
- Tone
- Positive 82/100
- Event
- Deals and strategy
- Published
- 13 Jun 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Is Amgen Inc. (AMGN) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Market source
TradingView
Direct company coverage
Amgen Secures EU Nod for Imdylltra in Lung Cancer Indication
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- TradingView
Market source
Direct company coverage
Novo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Amgen finance and R&D chiefs will speak in a public webcast May 13
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- Stock Titan
PR Newswire
Direct company coverage
AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- PR Newswire
simplywall.st
Direct company coverage
Amgen (AMGN) Margin Expansion In Q1 2026 Tests Cautious Growth Narratives
- Tone
- Positive 95/100
- Event
- Earnings
- Published
- 02 May 2026 07:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Two Days Left Until Amgen Inc. (NASDAQ:AMGN) Trades Ex-Dividend
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Feb 2026 08:00
- Source
- simplywall.st
Stocktwits
Direct company coverage
Amgen CEO Teases 2026 As ‘Springboard Year’ After 14 Blockbusters And 18 Record Products
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Feb 2026 08:00
- Source
- Stocktwits
Investing.com
Direct company coverage
Nasdaq falls 1.5% amid heavy rotation out of tech stocks; Amgen boosts Dow
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 03 Feb 2026 08:00
- Source
- Investing.com
The Globe and Mail
Direct company coverage
Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Dec 2025 08:00
- Source
- The Globe and Mail
simplywall.st
Direct company coverage
Don't Ignore The Insider Selling In Amgen
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Nov 2025 08:00
- Source
- simplywall.st
AJMC
Direct company coverage
Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Oct 2025 07:00
- Source
- AJMC